Nov 12, 2025
BioXcel Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on Late-Stage Clinical Programs for Agitation in Bipolar, Schizophrenia, and Alzheimer’s DiseaseVIEW RELEASE
Oct 14, 2025
BioXcel Therapeutics Announces Positive Results from Correlation Study Supporting SERENITY At-Home Exploratory Efficacy OutcomesVIEW RELEASE
Oct 13, 2025
BioXcel Therapeutics to Ring Nasdaq Closing Bell on October 14 to Celebrate a Transformative Milestone in Neuroscience InnovationVIEW RELEASE
Stock Information
BioXcel Therapeutics, Inc.
Nov 28, 2025 01:00 PM
MARKET/SYMBOL
Nasdaq:
BTAI
PRICE
2.25
CHANGE
0.17 (8.17%)
